What is the best long‐term management strategy for patients with primary adrenal insufficiency?
- 7 December 2011
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 76 (1), 21-25
- https://doi.org/10.1111/j.1365-2265.2011.04103.x
Abstract
Primary adrenal insufficiency is treated with glucocorticoid and mineralocorticoid replacement therapy. Recent data revealed that health-related quality of life in adrenal insufficiency is impaired in many patients and that patients with adrenal insufficiency are also threatened by an increased mortality and morbidity. This may be caused by inadequate glucocortiocid therapy and adrenal crisis. Therefore, the optimization of hormone replacement therapy remains one of the most challenging tasks in endocrinology because it is largely based on clinical grounds because of the lack of objective assessment tools. This article provides answers to the important daily clinical questions, such as correct dose finding, dose adaptation in special situations, e g, pregnancy, improvement of quality of life and measures for protection from adrenal crisis. Other important aspects discussed are side effects of glucocortiocid replacement therapy and interactions with other drugs.Keywords
This publication has 36 references indexed in Scilit:
- Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategiesActa Endocrinologica, 2010
- Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcriptionNature, 2009
- Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic studyActa Endocrinologica, 2009
- Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non‐HDL cholesterol and may diminish the association of HDL cholesterol with the –629C>A CETP promoter polymorphism in GH‐receiving hypopituitary patientsClinical Endocrinology, 2008
- Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurementsClinical Endocrinology, 2006
- Why is the management of glucocorticoid deficiency still controversial: a review of the literatureClinical Endocrinology, 2005
- Adrenal insufficiencyThe Lancet, 2003
- Therapie der Nebennierenrindeninsuffizienz*Deutsche Medizinische Wochenschrift (1946), 1994
- Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass.BMJ, 1987
- RIFAMPICIN AND CORTISONE REPLACEMENT THERAPYThe Lancet, 1974